A Phase I Dose Escalation Study of Intrathecal DepoFoam Encapsulated Cytarabine (DTC 101) in Pediatric Patients With Advanced Meningeal Malignancies
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 30 Mar 2010
At a glance
- Drugs Cytarabine (Primary)
- Indications Leukaemia; Lymphoma; Solid tumours
- Focus Adverse reactions
- 30 Mar 2010 Planned number of patients changed from 36 to 15 as reported by ClinicalTrials.gov.
- 25 Sep 2005 New trial record.